Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 937-949

  Wang, Shifeng ^a   Li, Yuhua ^a   Shi, Huoying ^a   Sun, Wei ^a   Roland, Kenneth L ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LIVE VACCINE; OUTER MEMBRANE PROTEIN; PAGC PROTEIN; SALMONELLOSIS VACCINE; SSAG PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENETIC TRANSCRIPTION; IMMUNIZATION; IMMUNOGENICITY; IN VIVO INDUCIBLE PROMOTER; MOUSE; NONHUMAN; PLASMID; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROMOTER REGION; REGULATED DELAYED ANTIGEN SYNTHESIS SYSTEM; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VECTORS; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS; PROMOTER REGIONS, GENETIC; SALMONELLA VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 79251525499     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00445-10     Document Type: Article

References (96)

1. Altboum, Z., E. M. Barry, G. Losonsky, J. E. Galen, and M. M. Levine. 2001. Attenuated Shigella flexneri 2a ΔguaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Infect. Immun. 69:3150-3158.
2. Altboum, Z., M. M. Levine, J. E. Galen, and E. M. Barry. 2003. Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain. Infect. Immun. 71:1352-1360.
3. Angelakopoulos, H., and E. L. Hohmann. 2000. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2135-2141.
4. Belden, W. J., and S. I. Miller. 1994. Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci. Infect. Immun. 62:5095-5101.
5. Bertani, G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
6. Beuzon, C. R., G. Banks, J. Deiwick, M. Hensel, and D. W. Holden. 1999. pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium. Mol. Microbiol. 33:806-816.
7. Bijlsma, J. J., and E. A. Groisman. 2005. The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica. Mol. Microbiol. 57:85-96.
8. Briles, D. E., et al. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
9. Bullifent, H. L., et al. 2000. Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters. Vaccine 18:2668-2676.
10. Bumann, D. 2002. Examination of Salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometry. Mol. Microbiol. 43:1269-1283.
11. +-T-cell responses. Infect. Immun. 69:7493-7500.
12. Chakravortty, D., M. Rohde, L. Jager, J. Deiwick, and M. Hensel. 2005. Formation of a novel surface structure encoded by Salmonella pathogenicity island 2. EMBO J. 24:2043-2052.
13. Chatfield, S. N., et al. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10:888-892.
14. Chen, H., and D. M. Schifferli. 2001. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector. Vaccine 19:3009-3018.
15. Chen, I., et al. 1998. A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect. Immun. 66:1648-1653.
16. Coombes, B. K., N. F. Brown, Y. Valdez, J. H. Brumell, and B. B. Finlay. 2004. Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL. J. Biol. Chem. 279:49804-49815.
17. Coombes, B. K., M. E. Wickham, M. J. Lowden, N. F. Brown, and B. B. Finlay. 2005. Negative regulation of Salmonella pathogenicity island 2 is required for contextual control of virulence during typhoid. Proc. Natl. Acad. Sci. U. S. A. 102:17460-17465.
18. Curtiss, R., III., et al. 2005. Antigen delivery systems II: development of live recombinant attenuated bacterial antigen and DNA vaccine delivery vector vaccines, p. 1009-1037. In J. Mestecky, M. E. Lamm, J. R. McGhee, J. Bienenstock, L. Mayer, and W. Strober (ed.), Mucosal immunology, 3rd ed. Academic Press, Burlington, MA.
19. Curtiss, R., III., et al. 1991. Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry, p. 169-198. In L. C. Blankenship, J. H. S. Bailey, N. A. Cox, N. J. Stern, and R. J. Meinersmann (ed.), Colonization control of human bacterial enteropathogens in poultry. Academic Press, New York, NY.
20. Curtiss, R., III., et al. 2007. Induction of host immune responses using Salmonella-vectored vaccines, p. 297-313. In K. A. Brogden, N. Cornick, T. B. Stanton, Q. Zhang, L. K. Nolan, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogens, 4th ed. ASM Press, Washington, DC.
21. Deiwick, J., T. Nikolaus, S. Erdogan, and M. Hensel. 1999. Environmental regulation of Salmonella pathogenicity island 2 gene expression. Mol. Microbiol. 31:1759-1773.
22. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 1999. Use of in vivoregulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium. Infect. Immun. 67:5133-5141.
23. Eriksson, S., S. Lucchini, A. Thompson, M. Rhen, and J. C. Hinton. 2003. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 47:103-118.
24. Eswarappa, S. M., G. Karnam, A. G. Nagarajan, S. Chakraborty, and D. Chakravortty. 2009. lac repressor is an antivirulence factor of Salmonella enterica: its role in the evolution of virulence in Salmonella. PLoS One 4:e5789.
25. Faucher, S. P., S. Porwollik, C. M. Dozois, M. McClelland, and F. Daigle. 2006. Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. Proc. Natl. Acad. Sci. U. S. A. 103:1906-1911.
26. Feng, X., R. Oropeza, and L. J. Kenney. 2003. Dual regulation by phospho-OmpR of ssrA/B gene expression in Salmonella pathogenicity island 2. Mol. Microbiol. 48:1131-1143.
27. Feng, X., D. Walthers, R. Oropeza, and L. J. Kenney. 2004. The response regulator SsrB activates transcription and binds to a region overlapping OmpR binding sites at Salmonella pathogenicity island 2. Mol. Microbiol. 54:823-835.
28. Fontana, M. R., et al. 2000. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 19:75-85.
29. C fragment. Vaccine 21:1052-1059.
30. Galen, J. E., et al. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708.
31. Galen, J. E., and M. M. Levine. 2001. Can a 'flawless' live vector vaccine strain be engineered? Trends Microbiol. 9:372-376.
32. Galen, J. E., et al. 1999. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun. 67:6424-6433.
33. Galen, J. E., et al. 2009. Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol. Cell Biol. 87:400-412.
34. Galen, J. E., et al. 2010. A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors. Infect. Immun. 78:337-347.
35. Garmendia, J., C. R. Beuzon, J. Ruiz-Albert, and D. W. Holden. 2003. The roles of SsrA-SsrB and OmpR-EnvZ in the regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion system. Microbiology 149: 2385-2396.
36. Heithoff, D. M., et al. 1997. Bacterial infection as assessed by in vivo gene expression. Proc. Natl. Acad. Sci. U. S. A. 94:934-939.
37. Hoffmann, F., J. Weber, and U. Rinas. 2002. Metabolic adaptation of Escherichia coli during temperature-induced recombinant protein production. 1. Readjustment of metabolic enzyme synthesis. Biotechnol. Bioeng. 80:313-319.
38. Hohmann, E. L., C. A. Oletta, K. P. Killeen, and S. I. Miller. 1996. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic singledose typhoid fever vaccine in volunteers. J. Infect. Dis. 173:1408-1414.
39. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage- inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. U. S. A. 92:2904-2908.
40. Hohmann, E. L., C. A. Oletta, and S. I. Miller. 1996. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14:19-24.
41. Hone, D., S. Attridge, L. van den Bosch, and J. Hackett. 1988. A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb. Pathog. 5:407-418.
42. Hu, K. F., J. Ekstrom, M. Merza, K. Lovgren-Bengtsson, and B. Morein. 1999. Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes. Med. Microbiol. Immunol. 187:191-198.
43. Huang, Y., G. Hajishengallis, and S. M. Michalek. 2000. Construction and characterization of a Salmonella enterica serovar Typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect. Immun. 68:1549-1556.
44. Husseiny, M. I., and M. Hensel. 2005. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines. Vaccine 23:2580-2590.
45. John, M., T. I. Crean, S. B. Calderwood, and E. T. Ryan. 2000. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect. Immun. 68:1171-1175.
46. Kang, H. Y., J. Srinivasan, and R. Curtiss III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
47. Kelly, A., et al. 2004. A global role for Fis in the transcriptional control of metabolism and type III secretion in Salmonella enterica serovar Typhimurium. Microbiology 150:2037-2053.
48. Khan, S., et al. 2007. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine 25:4175-4182.
49. Kim, C. C., and S. Falkow. 2004. Delineation of upstream signaling events in the Salmonella pathogenicity island 2 transcriptional activation pathway. J. Bacteriol. 186:4694-4704.
50. Konjufca, V., S. Y. Wanda, M. C. Jenkins, and R. Curtiss III. 2006. A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect. Immun. 74:6785-6796.
51. Lee, A. K., C. S. Detweiler, and S. Falkow. 2000. OmpR regulates the two-component system SsrA-ssrB in Salmonella pathogenicity island 2. J. Bacteriol. 182:771-781.
52. Lewis, G. K. 2007. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? Expert Rev. Vaccines 6:431-440.
53. Li, Y., et al. 2009. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U. S. A. 106:593-598.
54. Lim, S., B. Kim, H. S. Choi, Y. Lee, and S. Ryu. 2006. Fis is required for proper regulation of ssaG expression in Salmonella enterica serovar Typhimurium. Microb. Pathog. 41:33-42.
55. Linehan, S. A., A. Rytkonen, X. J. Yu, M. Liu, and D. W. Holden. 2005. SlyA regulates function of Salmonella pathogenicity island 2 (SPI-2) and expression of SPI-2-associated genes. Infect. Immun. 73:4354-4362.
56. Loessner, H., et al. 2007. Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell. Microbiol. 9:1529-1537.
57. Londono, L. P., et al. 1996. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine 14:545-552.
58. Londono-Arcila, P., et al. 2002. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect. Immun. 70:5096-5106.
59. Lu, Y. J., et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4:e1000159.
60. Lucchini, S., et al. 2006. H-NS mediates the silencing of laterally acquired genes in bacteria. PLoS Pathog. 2:e81.
61. McDermott, M. R., and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892-1898.
62. McKelvie, N. D., et al. 2004. Expression of heterologous antigens in Salmonella typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG. Vaccine 22:3243-3255.
63. McSorley, S. J., D. Xu, and F. Y. Liew. 1997. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect. Immun. 65:171-178.
64. Miller, V. L., K. B. Beer, W. P. Loomis, J. A. Olson, and S. I. Miller. 1992. An unusual pagC::TnphoA mutation leads to an invasion- and virulence-defective phenotype in salmonellae. Infect. Immun. 60:3763-3770.
65. Mollenkopf, H., G. Dietrich, and S. H. Kaufmann. 2001. Intracellular bacteria as targets and carriers for vaccination. Biol. Chem. 382:521-532.
66. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Nat. Biotechnol. 6:693-697.
67. Navarre, W. W., et al. 2005. Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol. Microbiol. 56:492-508.
68. Nordstrom, K., and B. E. Uhlin. 1992. Runaway-replication plasmids as tools to produce large quantities of proteins from cloned genes in bacteria. Nat. Biotechnol. 10:661-666.
69. Orr, N., J. E. Galen, and M. M. Levine. 2001. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA. Vaccine 19:1694-1700.
70. Paccez, J. D., et al. 2006. Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery. Vaccine 24:2935-2943.
71. Pascual, D. W., et al. 1999. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 67:6249-6256.
72. Pashine, A., B. John, S. Rath, A. George, and V. Bal. 1999. Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence. Int. Immunol. 11:481-489.
73. Poirier, K., et al. 2008. Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect. Immun. 76:4814-4822.
74. Pulkkinen, W. S., and S. I. Miller. 1991. A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J. Bacteriol. 173:86-93.
75. Ramarathinam, L., D. W. Niesel, and G. R. Klimpel. 1993. Salmonella typhimurium induces IFN-γ production in murine splenocytes. Role of natural killer cells and macrophages. J. Immunol. 150:3973-3981.
76. Rathman, M., M. D. Sjaastad, and S. Falkow. 1996. Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect. Immun. 64:2765-2773.
77. Roberts, M., J. Li, A. Bacon, and S. Chatfield. 1998. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. Infect. Immun. 66:3080-3087.
78. Schödel, F., S. M. Kelly, D. L. Peterson, D. R. Milich, and R. Curtiss III. 1994. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 62:1669-1676.
79. Sirard, J. C., M. Weber, E. Duflot, M. R. Popoff, and M. Mock. 1997. A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins. Infect. Immun. 65:2029-2033.
80. Spreng, S., G. Dietrich, and G. Weidinger. 2006. Rational design of Salmonella-based vaccination strategies. Methods 38:133-143. (Pubitemid 43163474)
81. Stocker, B. A. 2000. Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J. Biotechnol. 83:45-50.
82. Stratford, R., et al. 2005. Optimization of Salmonella enterica serovar Typhi ΔaroC ΔssaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters. Infect. Immun. 73:362-368.
83. Tacket, C. O., et al. 2000. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol. 97:146-153.
84. Terry, T. D., J. E. Downes, S. J. Dowideit, A. N. Mabbett, and M. P. Jennings. 2005. Investigation of ansB and sspA derived promoters for multi- and single-copy antigen expression in attenuated Salmonella enterica var. Typhimurium. Vaccine 23:4521-4531.
85. Torres-Escobar, A., et al. 2010. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar Typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infect. Immun. 78:2529-2543.
86. Tzschaschel, B. D., C. A. Guzmán, K. N. Timmis, and V. de Lorenzo. 1996. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. Nat. Biotechnol. 14:765-769.
87. Valdivia, R. H., and S. Falkow. 1997. Fluorescence-based isolation of bacterial genes expressed within host cells. Science 277:2007-2011.
88. Van Gerven, N., V. Derous, and J. P. Hernalsteens. 2008. Expression of in vivo-inducible Salmonella enterica promoters during infection of Caenorhabditis elegans. FEMS Microbiol. Lett. 278:236-241.
89. Walthers, D., et al. 2007. The response regulator SsrB activates expression of diverse Salmonella pathogenicity island 2 promoters and counters silencing by the nucleoid-associated protein H-NS. Mol. Microbiol. 65:477-493.
90. Wang, J., V. Michel, C. Leclerc, M. Hofnung, and A. Charbit. 1999. Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K-12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium. Vaccine 17:1-12.
91. Wang, S., et al. 2010. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun. 78:3969-3980.
92. Wang, S., et al. 2010. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect. Immun. 78:3258-3271.
93. Weiss, S., and T. Chakraborty. 2001. Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers. Curr. Opin. Biotechnol. 12:467-472.
94. Xu, D., et al. 1998. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-α, and IFN-γ administered orally via attenuated Salmonella typhimurium. J. Immunol. 160:1285-1289.
95. Xu, X., M. I. Husseiny, A. Goldwich, and M. Hensel. 2010. Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines. Infect. Immun. 78:4828-4838.
96. Yang, X., et al. 2007. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J. Immunol. 178:1059-1067.